CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
CRYO CELL INTERNATIONAL INC
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026
$4.65+0.23 (+5.20%)
Close on Oct 19, 2026
- Market cap
- $37.50M
- P/E (TTM)
- –
- Dividend yield
- –
CRYO CELL INTERNATIONAL INC revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Umbilical Cord Blood and Cord Tissue Stem Cell Service [Member] | $7.72M | $7.64M | $7.82M | $7.82M | $7.87M | $7.87M | $7.84M | $7.95M | $7.97M | $7.81M | $7.79M | $7.86M | 99.2% | -2.0% |
| Public Cord Blood Banking [Member] | $46.49K | $1.41K | $627 | $4.12K | $42.69K | $82.08K | $160.87K | $120.61K | $41.48K | $43.71K | $82.25K | $4.38K | 0.6% | +8.9% |
| PrepaCyte CB [Member] | $14.18K | $38.59K | $18.32K | $436 | $14.44K | $20.91K | $28.41K | $636 | $35.83K | $3.00K | $4.54K | $2.54K | 0.2% | -1.8% |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Umbilical Cord Blood and Cord Tissue Stem Cell Service [Member] | $1.26M | $837.87K | $488.96K | $2.03M | $1.65M | $1.24M | $16.23K | $1.54M | $1.52M | $1.06M | -$12.25M | $1.34M | -23.5% |
| PrepaCyte CB [Member] | $8.15K | $26.16K | $8.33K | -$4.34K | $3.21K | $7.01K | $13.47K | -$7.53K | $18.51K | -$29.43K | -$10.47K | -$5.38K | +154.0% |
| Public Cord Blood Banking [Member] | -$69.94K | -$98.89K | -$4.46M | -$128.05K | -$157.46K | -$193.92K | -$152.04K | -$144.93K | -$142.50K | -$207.07K | -$3.92M | -$174.90K | -55.6% |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Processing and Storage Fees [Member] | $7.72M | $7.64M | $7.82M | $7.82M | $7.87M | $7.87M | $7.84M | $7.95M | $7.97M | $7.81M | $7.79M | $7.86M | 99.2% | -2.0% |
| Public Banking Revenue [Member] | $46.49K | $1.41K | $627 | $4.12K | $42.69K | $82.08K | $160.87K | $120.61K | $41.48K | $43.71K | $82.25K | $4.38K | 0.6% | +8.9% |
| Product Revenue [Member] | $14.18K | $38.59K | $18.32K | $436 | $14.44K | $20.91K | $28.41K | $636 | $35.83K | $3.00K | $4.54K | $2.54K | 0.2% | -1.8% |
By region
From the segment and revenue-disaggregation notes of Cryo Cell International's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.